Anti-NT2NB/ NOTCH2NLB/ N2N functional antibody

Anti-NT2NB/ NOTCH2NLB/ N2N functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to NOTCH2NLB/NOTCH2NLB products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1130-Ab-1/ GM-Tg-hg-SE1130-Ab-2Anti-Human NOTCH2NLB monoclonal antibodyHuman
GM-Tg-rg-SE1130-Ab-1/ GM-Tg-rg-SE1130-Ab-2Anti-Rat NOTCH2NLB monoclonal antibodyRat
GM-Tg-mg-SE1130-Ab-1/ GM-Tg-mg-SE1130-Ab-2Anti-Mouse NOTCH2NLB monoclonal antibodyMouse
GM-Tg-cynog-SE1130-Ab-1/ GM-Tg-cynog-SE1130-Ab-2Anti-Cynomolgus/ Rhesus macaque NOTCH2NLB monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1130-Ab-1/ GM-Tg-felg-SE1130-Ab-2Anti-Feline NOTCH2NLB monoclonal antibodyFeline
GM-Tg-cang-SE1130-Ab-1/ GM-Tg-cang-SE1130-Ab-2Anti-Canine NOTCH2NLB monoclonal antibodyCanine
GM-Tg-bovg-SE1130-Ab-1/ GM-Tg-bovg-SE1130-Ab-2Anti-Bovine NOTCH2NLB monoclonal antibodyBovine
GM-Tg-equg-SE1130-Ab-1/ GM-Tg-equg-SE1130-Ab-2Anti-Equine NOTCH2NLB monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1130-Ab-1/ GM-Tg-hg-SE1130-Ab-2; GM-Tg-rg-SE1130-Ab-1/ GM-Tg-rg-SE1130-Ab-2;
GM-Tg-mg-SE1130-Ab-1/ GM-Tg-mg-SE1130-Ab-2; GM-Tg-cynog-SE1130-Ab-1/ GM-Tg-cynog-SE1130-Ab-2;
GM-Tg-felg-SE1130-Ab-1/ GM-Tg-felg-SE1130-Ab-2; GM-Tg-cang-SE1130-Ab-1/ GM-Tg-cang-SE1130-Ab-2;
GM-Tg-bovg-SE1130-Ab-1/ GM-Tg-bovg-SE1130-Ab-2; GM-Tg-equg-SE1130-Ab-1/ GM-Tg-equg-SE1130-Ab-2
Products NameAnti-NOTCH2NLB monoclonal antibody
Formatmab
Target NameNOTCH2NLB
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-NOTCH2NLB benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1130-Ag-1Recombinant multi-species NT2NB/ NOTCH2NLB/ N2N protein


    Target information

    Target IDGM-SE1130
    Target NameNOTCH2NLB
    Gene ID100996763
    Gene Symbol and SynonymsN2N,NOTCH2NL,NOTCH2NLA,NOTCH2NLB
    Uniprot AccessionP0DPK3
    Uniprot Entry NameNT2NB_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000286019
    Target ClassificationN/A

    The target: NOTCH2NLB, gene name: NOTCH2NLB, also named as N2N, NOTCH2NL, NOTCH2NLA. Enables Notch binding activity. Involved in cerebral cortex development and positive regulation of Notch signaling pathway. Located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.